Rising Preference for Less Invasive Treatments Drives Market Adoption of Endoluminal Suturing Devices
The global endoluminal suturing devices market is witnessing substantial expansion as healthcare systems increasingly adopt minimally invasive treatment approaches. The growing prevalence of gastrointestinal disorders, obesity-related conditions, and demand for advanced endoscopic interventions is accelerating the adoption of endoluminal suturing technologies across hospitals and specialty care centers worldwide.

As healthcare providers continue prioritizing faster recovery times, reduced complications, and improved patient outcomes, advanced suturing systems are becoming an integral component of modern therapeutic endoscopy. Similar to rapidly evolving sectors that focus on market size, share, trends, and growth opportunities, the endoluminal suturing devices market is benefiting from continuous technological innovation and expanding clinical applications.

According to the latest market assessment, the global endoluminal suturing devices market size was valued at USD 110.8 million in 2025 and is projected to grow from USD 122.62 million in 2026 to USD 275.95 million by 2034, registering a CAGR of 10.67% during the forecast period (2026–2034).

The increasing utilization of therapeutic endoscopy for tissue approximation, defect closure, bariatric procedures, and gastrointestinal repair is expected to create significant growth opportunities for manufacturers operating in this highly specialized medical device segment.

Key Highlights
The global endoluminal suturing devices market was valued at USD 110.8 million in 2025.
The market is projected to reach USD 275.95 million by 2034.
The market is expected to expand at a CAGR of 10.67% during 2026–2034.
North America holds the largest share of the global market.
Asia-Pacific is anticipated to be the fastest-growing regional market during the forecast period.
By product type, Endoscopic Suturing Systems account for the largest market share.
By application, Bariatric Procedures represent the dominant segment.
By end user, Hospitals remain the leading revenue-generating segment.
The bariatric procedures segment is expected to witness the fastest growth during the forecast period.
Market Dynamics
Market Driver
The rising incidence of gastrointestinal diseases and obesity-related disorders is significantly driving demand for endoluminal suturing devices. Healthcare professionals increasingly rely on minimally invasive endoscopic procedures to manage complex gastrointestinal conditions while reducing hospitalization duration and postoperative complications. Endoluminal suturing technologies offer enhanced precision, improved tissue closure capabilities, and better procedural efficiency, making them highly valuable in therapeutic endoscopy.

Another major growth catalyst is the increasing popularity of endoscopic bariatric procedures. As obesity rates continue to rise globally, patients and clinicians are seeking alternatives to conventional surgical interventions. Endoluminal suturing devices enable less invasive weight-management procedures that offer shorter recovery periods and lower procedural risks, supporting broader adoption across healthcare facilities.

Market Restraint
Despite favorable growth prospects, the market faces challenges associated with the high cost of advanced endoscopic suturing systems and related procedural expenses. Smaller healthcare institutions and facilities in cost-sensitive regions may experience budget constraints that limit widespread adoption of sophisticated endoscopic technologies.

Furthermore, successful utilization of endoluminal suturing devices requires specialized physician training and technical expertise. The limited availability of highly skilled endoscopists in certain regions may create barriers to procedural adoption and restrict market penetration.

Market Opportunity
Technological advancements in endoscopic platforms, visualization systems, and robotic-assisted procedures are creating promising growth opportunities for market participants. Manufacturers are focusing on developing user-friendly, highly precise, and efficient suturing devices capable of supporting increasingly complex gastrointestinal interventions.

Additionally, expanding healthcare infrastructure across emerging economies is expected to unlock substantial market potential. Rising healthcare expenditures, growing awareness of minimally invasive treatment options, and increasing investments in advanced endoscopy centers are likely to strengthen market demand throughout the forecast period.

Top Market Players
Apollo Endosurgery, Inc.
Medtronic plc
Olympus Corporation
Johnson & Johnson
Boston Scientific Corporation
STERIS plc
Cook Medical
CONMED Corporation
Endo Tools Therapeutics S.A.
Erbe Elektromedizin GmbH
Market Segmentation
By Product Type
Endoscopic Suturing Systems
Accessories and Consumables
By Application
Bariatric Procedures
Gastrointestinal Defect Closure
Stent Fixation
Endoscopic Resection Closure
Others
By End User
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Regional Analysis
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
India
Japan
South Korea
Australia
Rest of Asia-Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa
Unlock Full Report Insights and Strategic Analysis- https://straitsresearch.com/report/endoluminal-suturing-devices-market

Access comprehensive market intelligence featuring detailed competitive analysis, technological advancements, regulatory developments, investment opportunities, regional outlooks, strategic initiatives, emerging trends, and future growth prospects shaping the global endoluminal suturing devices market through 2034.

About Us
Straits Research is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports.

Contact Us
Email: [email protected]

Tel: +1 646 905 0080 (U.S.)

Tel: +44 203 695 0070 (U.K.)